Filing Details
- Accession Number:
- 0001209191-18-010105
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-14 18:06:40
- Reporting Period:
- 2018-02-12
- Accepted Time:
- 2018-02-14 18:06:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1242825 | M Jeffrey Leiden | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Ceo & President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-02-12 | 6,100 | $149.22 | 208,463 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-12 | 4,305 | $150.44 | 204,158 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-12 | 10,100 | $151.23 | 194,058 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-12 | 1,200 | $152.40 | 192,858 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-12 | 2,000 | $153.29 | 190,858 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-12 | 200 | $153.89 | 190,658 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 440 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $149.22 (range $148.77 to $149.74).
- Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $150.44 (range $149.79 to $150.76).
- Open market sales reported on this line occurred at a weighted average price of $151.23 (range $150.83 to $151.82).
- Open market sales reported on this line occurred at a weighted average price of $152.40 (range $151.85 to $152.81).
- Open market sales reported on this line occurred at a weighted average price of $153.29 (range $152.88 to $153.84).
- Open market sales reported on this line occurred at a weighted average price of $153.89 (range $153.88 to $153.89).
Billionaire Hedge Funds
